Cargando…

In Vitro Assessment of Magnetic Liposomal Paclitaxel Nanoparticles as a Potential Carrier for the Treatment of Ovarian Cancer

Purpose: This study aimed to evaluate the role of magnetic liposome nanoparticles (ML NPs) as a carrier for paclitaxel (PTX) for the treatment of ovarian cancer in vitro. Methods: Magnetic NPs (MNPs) were synthesized by chemical co-precipitation method. The resulting NPs were characterized in terms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yousefi Aldashi, Sara, Saffari, Zahra, Ebrahimi Shahmabadi, Hasan, Akbarzadeh, Azim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046399/ https://www.ncbi.nlm.nih.gov/pubmed/33880348 http://dx.doi.org/10.34172/apb.2021.039

Ejemplares similares

Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation
por: Ghaferi, Mohsen, et al.
Publicado: (2020)

Enhancing the efficacy of albendazole for liver cancer treatment using mesoporous silica nanoparticles: an in vitro study
por: Ghaferi, Mohsen, et al.
Publicado: (2022)

Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma
por: Ghaferi, Mohsen, et al.
Publicado: (2022)

Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2019)

General Characteristics and Cytotoxic Effects of Nano-Poly (Butyl Cyanoacrylate) Containing Carboplatin on Ovarian Cancer Cells
por: Kanaani, Leila, et al.
Publicado: (2017)

Effects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells
por: Kanaani, Leila, et al.
Publicado: (2017)

Toxicity of Cisplatin-Loaded Poly Butyl Cyanoacrylate Nanoparticles in a Brain Cancer Cell Line: Anionic Polymerization Results
por: Mohamadi, Nejad, et al.
Publicado: (2017)

In Vitro Co-Delivery Evaluation of Novel Pegylated Nano-Liposomal Herbal Drugs of Silibinin and Glycyrrhizic Acid (Nano-Phytosome) to Hepatocellular Carcinoma Cells
por: Ochi, Mohammad Mahdi, et al.
Publicado: (2016)

Enhancing Effects of Curcumin on Cytotoxicity of Paclitaxel, Methotrexate and Vincristine in Gastric Cancer Cells
por: Ebrahimifar, Meysam, et al.
Publicado: (2017)

Preparation, Characterization, and Evaluation of Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved In Vitro and In Vivo Anticancer Activities
por: Ghaferi, Mohsen, et al.
Publicado: (2020)

Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
por: Tan, Xiangbin, et al.
Publicado: (2023)

Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel
por: Liu, Yongjin, et al.
Publicado: (2011)

A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2022)

Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics
por: Hassan, Md. Musfizur, et al.
Publicado: (2023)

Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
por: Karaosmanoglu, Sena, et al.
Publicado: (2022)

Development and In Vitro Evaluation of Liposomes Using Soy Lecithin to Encapsulate Paclitaxel
por: Nguyen, Thi Lan, et al.
Publicado: (2017)

In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin
por: Ashrafzadeh, Maryam Sadat, et al.
Publicado: (2020)

Anthelmintics for drug repurposing: Opportunities and challenges
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2021)

Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo
por: Yao, Shu, et al.
Publicado: (2018)

Pre-Targeting and Direct Immunotargeting of Liposomal Drug Carriers to Ovarian Carcinoma
por: Lehtinen, Julia, et al.
Publicado: (2012)

Preparation and in vitro evaluation of an acidic environment-responsive liposome for paclitaxel tumor targeting
por: Wang, Lianqin
Publicado: (2017)

Neutrophil as a Carrier for Cancer Nanotherapeutics: A Comparative Study of Liposome, PLGA, and Magnetic Nanoparticles Delivery to Tumors
por: Garanina, Anastasiia S., et al.
Publicado: (2023)

Liposomes Loaded with Cisplatin and Magnetic Nanoparticles: Physicochemical Characterization, Pharmacokinetics, and In-Vitro Efficacy
por: Toro-Cordova, Alfonso, et al.
Publicado: (2018)

Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment
por: Zhang, Xiaoyang, et al.
Publicado: (2017)

Formulation and Characterization of Poly (Ethylene Glycol)-Coated Core-Shell Methionine Magnetic Nanoparticles as a Carrier for Naproxen Delivery: Growth Inhibition of Cancer Cells
por: Yeganeh, Faten Eshrati, et al.
Publicado: (2022)

Efficacy and safety of liposome-paclitaxel/liposome-paclitaxel combined with S-1 in 17 advanced gastric cancer patients with poor performance status
por: Wu, Runhong, et al.
Publicado: (2019)

Effects of paclitaxel and cisplatin on in vitro ovarian follicle development
por: Kim, Yoon Young, et al.
Publicado: (2019)

Exosome/Liposome-like Nanoparticles: New Carriers for CRISPR Genome Editing in Plants
por: Alghuthaymi, Mousa A., et al.
Publicado: (2021)

Ovarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor gene
por: Ntemou, E., et al.
Publicado: (2022)

Development of Thermo- and pH-Sensitive Liposomal Magnetic Carriers for New Potential Antitumor Thienopyridine Derivatives
por: Ribeiro, Beatriz C., et al.
Publicado: (2022)

Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles
por: Martins, Susana, et al.
Publicado: (2007)

Resorbable GBR Scaffolds in Oral and Maxillofacial Tissue Engineering: Design, Fabrication, and Applications
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2023)

Fusogenic liposome-enhanced cytosolic delivery of magnetic nanoparticles
por: Chen, Fang, et al.
Publicado: (2021)

Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer
por: Okamoto, Yuko, et al.
Publicado: (2019)

Nature-Inspired Nanoparticles as Paclitaxel Targeted Carrier for the Treatment of HER2-Positive Breast Cancer
por: Nieto, Celia, et al.
Publicado: (2021)

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
por: Kavanagh, John J, et al.
Publicado: (2010)

Pegylated liposomal-paclitaxel induces ovarian cancer cell apoptosis via TNF-induced ERK/AKT signaling pathway
por: Qi, Zhiying, et al.
Publicado: (2018)

Chitosan nanoparticle loaded by epidermal growth factor as a potential protein carrier for wound healing: In vitro and in vivo studies
por: Montazeri, Samaneh, et al.
Publicado: (2023)

Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation
por: Hong, Soon-Seok, et al.
Publicado: (2016)

Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine
por: Jiang, Xing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a4opsbikh9lmbfg9sl3sjdgefn